Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
- 1 January 2017
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 23 (1) , 21-25
Abstract
The eIF4F complex regulates the cap-dependent mRNA translation process. It is becoming increasingly evident that aberrant activity of this complex is observed in many cancers, leading to the selective synthesis of proteins involved in tumor growth and metastasis. The selective translation of cellular mRNAs controlled by this complex also contributes to resistance to cancer treatments, and downregulation of the eIF4F complex components can restore sensitivity to various cancer therapies. Here, we review the contribution of the eIF4F complex to tumorigenesis, with a focus on its role in chemoresistance as well as the promising use of new small-molecule inhibitors of the complex, including flavaglines/rocaglates, hippuristanol, and pateamine A. Clin Cancer Res; 23(1); 21–25. ©2016 AACR.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4ABlood Cancer Journal, 2013
- The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa inductionBritish Journal of Cancer, 2012
- PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axisProceedings of the National Academy of Sciences, 2011
- Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia CellsThe AAPS Journal, 2011
- Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4FProceedings of the National Academy of Sciences, 2010
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionProceedings of the National Academy of Sciences, 2010
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor CellsJournal of Biological Chemistry, 2009
- Potentin vitroandin vivoanticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine AMolecular Cancer Therapeutics, 2009
- Dissecting eIF4E action in tumorigenesisGenes & Development, 2007
- Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4ANature Chemical Biology, 2006